Institutional Ownership Phathom Pharmaceuticals, Inc. (PHAT)
This table provides information about the institutional ownership of Phathom Pharmaceuticals, Inc. (PHAT). We have compiled data on the 144 institutions that hold shares in the stock, with a total of 73.6 Million shares, which have been reported (via 13F filing form) to have a value of $684 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Wipfli Financial Advisors Llc,
|
Oct 26, 2022 Q3 2022 |
115
shares
|
$1,026
0.0% of portfolio
|
Q3 2022
New holding
|
|
Nisa Investment Advisors, LLC
|
Oct 24, 2024 Q3 2024 |
112
shares
|
$1,000
0.0% of portfolio
|
Q3 2024
Added 33.33%
|
|
Sterling Capital Management LLC
Charlotte, NC |
Nov 12, 2024 Q3 2024 |
106
shares
|
$946
0.0% of portfolio
|
Q3 2024
New holding
|
|
Riggs Asset Managment Co. Inc.
|
Oct 24, 2024 Q3 2024 |
69
shares
|
$616
0.0% of portfolio
|
Q1 2024
New holding
|
|
Rothschild Investment LLC
Chicago, IL |
Oct 18, 2024 Q3 2024 |
65
shares
|
$580
0.0% of portfolio
|
Q3 2024
Added 225.0%
|
|
Aster Capital Management (Difc) LTD
Dubai, C0 |
Nov 13, 2024 Q3 2024 |
45
shares
|
$401
0.0% of portfolio
|
Q3 2024
New holding
|
|
Russell Investments Group, Ltd.
|
Nov 13, 2024 Q3 2024 |
36
shares
|
$321
0.0% of portfolio
|
Q3 2024
Reduced 93.08%
|
|
Cwm, LLC
|
Oct 08, 2024 Q3 2024 |
32
shares
|
$285
0.0% of portfolio
|
Q3 2024
Added 300.0%
|
|
Capital Performance Advisors LLP
|
Nov 01, 2024 Q3 2024 |
29
shares
|
$258
0.0% of portfolio
|
Q3 2024
New holding
|
|
Farther Finance Advisors, LLC
San Francisco, CA |
Oct 28, 2024 Q3 2024 |
27
shares
|
$241
0.0% of portfolio
|
Q2 2024
Added 58.82%
|
|
Zrc Wealth Management, LLC
Santa Rosa, CA |
Oct 04, 2024 Q3 2024 |
20
shares
|
$178
0.0% of portfolio
|
Q3 2023
New holding
|
|
Srs Capital Advisors, Inc.
Denver, CO |
Nov 06, 2024 Q3 2024 |
17
shares
|
$151
0.0% of portfolio
|
Q2 2024
New holding
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|